Sievers Eclipse Bacterial Endotoxins Testing (BET) Platform
Sievers ground-breaking Eclipse platform delivers a consistent and conscious bacterial endotoxins testing with robust analytical performance and regulatory compliance.
![Product Image](https://www.svan.in/images/products/Eclipse.png)
![Arrow Down](https://www.svan.in/images/icons/arrow-down.png)
Regulatory Compliance
With usage of FDA licensed Limulus Amoebocyte Lysate (LAL), Sievers Eclipse BET platform meets all requirements of the harmonized global pharmacopoeia with unmatched performance and efficiency.
Precision-crafted features
The Eclipse platform dramatically streamlines assay setup that results in 89% reduction in pipetting steps, 85% reduction in labor and 90% reduction in expensive LAL reagent use.
![Lab Image](https://www.svan.in/images/homepage/lab.png)
Benefit 1
Enables fully compliant, 21-sample assay setup in as little as 9 minutes
![Lab Image](https://www.svan.in/images/homepage/lab.png)
Benefit 2
Reduces Limulus Amebocyte Lysate (LAL) reagent use by up to 90%
![Lab Image](https://www.svan.in/images/homepage/lab.png)
Benefit 3
Meets all requirements of the harmonized pharmacopoeia: USP <85>, EP 2.6.14 and JP 4.01
Download details
Download details